LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Reset all filters
01 1LGM Pharma
02 3Symbiotec Pharmalab
03 1DKSH
04 1Capital Farma
05 1TAPI Technology & API Services
06 1Beijing Mesochem Technology
07 1ASG Biochem
08 1Aurisco Pharmaceutical
09 1Bayer AG
10 1CHEMO
11 1Cipla
12 1Curia
13 5Gedeon Richter
14 1Guangzhou Tosun Pharmaceutical
15 1Hangzhou Deli Chemical
16 1Hubei Gedian Humanwell Pharmaceutical
17 3Industriale Chimica
18 1Lupin Ltd
19 2NEWCHEM SPA
20 1Nanjing Bold Chemical
21 1Qingdao Qingmei Biotech
22 1Quimica Sintetica
23 1Sicor
24 1Sicor Societa Italiana Corticosteroidi Srl
25 1Sicor Spa
26 2Sterling Chemical Malta
27 2Sterling Spa
28 1Sun Pharmaceutical Industries Limited
29 1Swati Spentose
30 1Symbiotica Specialty Ingredients
31 1Teva Pharmaceutical Industries
32 1Zhejiang Xianju Junye Pharmaceutical Co. LTD
Reset all filters
01 8China
02 1Germany
03 5Hungary
04 8India
05 2Israel
06 10Italy
07 1Malaysia
08 2Malta
09 3Spain
10 1Switzerland
11 2U.S.A
Reset all filters
01 10Active
02 33Blank
01 16Valid
02 1Withdrawn by Holder
03 26Blank
Reset all filters
01 1303MF10024
02 1305MF10096
03 1305MF10112
04 1306MF10029
05 1306MF10044
06 38Blank
Reset all filters
01 1WC-0161A2
02 2WC-0162A2
03 1WC-0168
04 39Blank
Reset all filters
01 1309-2-ND
02 1434-44-ND
03 1711-13-ND
04 1No. 2395-2-ND(1)
05 1Number 133-13-ND
06 1Su2395-2-ND
07 1Su258-26-ND
08 36Blank
Reset all filters
01 124002-0002
02 124002-0037
03 151508-013
04 152128-155
05 153069-0990
06 153183-9037
07 159057-014
08 159057-015
09 163190-0230
10 163190-0240
11 163190-0460
12 164918-1401
13 164918-1903
14 30Blank
01 43Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32885
Submission : 2018-08-30
Status : Active
Type : II
Certificate Number : CEP 2018-118 - Rev 01
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 2404
Status : Valid
Date of Issue : 2022-09-30
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162A2
Address of the Firm :
Capital Farma, a leading European pharmaceutical company focusing on the development & distribution of niche APIs & Pharma Services.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-23
Pay. Date : 2012-11-08
DMF Number : 22878
Submission : 2009-06-18
Status : Active
Type : II
Available Reg Filing : ASMF |
Date of Issue : 2022-07-05
Valid Till : 2025-07-02
Written Confirmation Number : WC-0161A2
Address of the Firm :
Date of Issue : 2022-08-31
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162A2
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-07-08
Pay. Date : 2013-04-24
DMF Number : 21733
Submission : 2008-06-27
Status : Active
Type : II
Certificate Number : R1-CEP 2009-193 - Rev 00
Issue Date : 2015-08-20
Type : Chemical
Substance Number : 2404
Status : Valid
NDC Package Code : 64918-1903
Start Marketing Date : 2019-11-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23580
Submission : 2010-08-16
Status : Active
Type : II
Date of Issue : 2022-08-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
65
PharmaCompass offers a list of Drospirenone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Drospirenone manufacturer or Drospirenone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Drospirenone manufacturer or Drospirenone supplier.
PharmaCompass also assists you with knowing the Drospirenone API Price utilized in the formulation of products. Drospirenone API Price is not always fixed or binding as the Drospirenone Price is obtained through a variety of data sources. The Drospirenone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BRN 4765500 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BRN 4765500, including repackagers and relabelers. The FDA regulates BRN 4765500 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BRN 4765500 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BRN 4765500 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BRN 4765500 supplier is an individual or a company that provides BRN 4765500 active pharmaceutical ingredient (API) or BRN 4765500 finished formulations upon request. The BRN 4765500 suppliers may include BRN 4765500 API manufacturers, exporters, distributors and traders.
click here to find a list of BRN 4765500 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 32 companies offering BRN 4765500
Get in contact with the supplier of your choice: